TITLE

PhRMA Names CEO

PUB. DATE
August 2010
SOURCE
Pharmaceutical Representative;Aug2010, Vol. 40 Issue 8, p8
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article announces that John Castellani was appointed president and chief executive officer (CEO) of PhRMA in the U.S.
ACCESSION #
52817402

 

Related Articles

  • The CEOs'top man in town. Snyder, Jim // Hill;9/16/2009, Vol. 16 Issue 103, p20 

    The article presents a profile of Business Roundtable president John Castellani.

  • Castellani Poised to Succeed Tauzin as CEO at PhRMA.  // Chain Drug Review;8/30/2010, Vol. 32 Issue 14, p108 

    The article announces that John Castellani will become the president and chief executive officer (CEO) of the Pharmaceutical Research and Manufacturers of America (PhRMA).

  • Business Roundtable's Castellani replaces Tauzin. Arnold, Matthew // Medical Marketing & Media;Aug2010, Vol. 45 Issue 8, p8 

    The article announces that John Castellani was appointed president and chief executive officer (CEO) at Pharmaceutical Research and Manufacturers of America.

  • John Castellani: Industry's Level Bet on a Dizzying Future. Looney, William // Pharmaceutical Executive;Mar2011, Vol. 31 Issue 3, p32 

    An interview with John Castellani, chief executive officer (CEO) of the Pharmaceutical Research and Manufacturers of America (PhRMA), is presented. He states that the biopharmaceuticals industry is at a critical point and ends up depending on decisions made. He cites that PhRMA will explain to...

  • PhRMA's Castellani Wins Recognition.  // Chain Drug Review;5/18/2015, Vol. 37 Issue 8, p71 

    The article announces that John Castellani, president and chief executive officer (CEO) at the Pharmaceutical Research and Manufacturers of America (PhRMA), has received a leadership award from the National Minority Quality Forum.

  • A warning IT can't ignore. Rapoza, Jim // eWeek;5/31/2004, Vol. 21 Issue 22, p47 

    The article presents an overview of software vendors and product security. The Business Roundtable CEOs are clearly stating that the software industry has not done enough to ensure the quality of its products and has, in fact, made the job of securing company assets harder than it should be. And...

  • Drug Makers Need to Adapt to Changing Business Climate.  // Chain Drug Review;4/25/2011, Vol. 33 Issue 8, p212 

    The article reports on the concerns expressed by John Castellani, president and chief executive officer (CEO) of Pharmaceutical and Research Manufacturers of America (PhRMA), regarding the need for drug manufacturers in the U.S. to conform with the critical structural and economic challenges in...

  • Castellanie weighs in on biotech.  // Chain Drug Review;1/2/2012, Vol. 34 Issue 1, p86 

    The article reports on the statement of Pharmaceutical Research and Manufacturers president and chief executive officer John Castellani regarding government leadership is needed to help keep U.S. biopharmaceutical research companies competitive in the global export market.

  • Selecting Leaders. Fernandez, Jorge E. // Executive Excellence;Feb2003, Vol. 20 Issue 2, p14 

    Focuses on the recruitment, selection and development practices of chief executive officers (CEO) in the U.S. Assessment of the behavioral style of CEO; Factors considered in promotion of executive; Behavioral characteristics of CEO.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics